Pharma shares advance; Cadila Healthcare floods 15% Kumar Jeetendra | March 20, 2020 Pharma shares were exchanging the green in Friday’s meeting with their sectoral list exchanging higher. Portions of Cadila Healthcare (up 15.09 percent), Dr Reddys Laboratories (up 7.41 percent), Cipla (up 5.8 percent), Biocon (up 5.63 percent), Glenmark Pharmaceuticals (up 4.98 percent), Divis Laboratories (up 4.87 percent), Aurobindo Pharma (up 4.34 percent), Sun Pharmaceutical Industries (up …
Pfizer and BioNTech declare joint advancement of a potential COVID-19 antibody Kumar Jeetendra | March 19, 2020 Pharma mammoth Pfizer declared on Tuesday that it’s dealing with a potential COVID-19 antibody with BioNTech, a German organization taking a shot at new sorts of immunotherapy medicines. The joint exertion, affirmed Tuesday by means of a marked letter of aim, will see the two accomplices cooperate on an envoy RNA-based antibody that will try …
Alembic Pharma share value sheds 4% as USFDA issues 4 perceptions Kumar Jeetendra | March 16, 2020 Alembic Pharmaceuticals share value falls more than 4 percent in early exchange on March 16 after the organization got 4 perceptions from the USFDA. US Food and Drug Administration (USFDA) has directed an investigation at the organization’s general oral strong plan office situated at Panelav from March 9 to 13, 2020. This was a booked …
Pfizer, Merck KGaA’s Bavencio pierced by Javelin in head and neck malignancy Kumar Jeetendra | March 14, 2020 Pfizer and Merck KGaA’s Bavencio tossed another Javelin however missed their objective in head and neck malignant growth. Adding Bavencio to chemoradiotherapy didn’t furnish a lot of additional advantage to patients with beforehand untreated privately progressed squamous cell carcinoma of the head and neck, the pair uncovered Friday. The autonomous information checking advisory group found …
Zydus Cadila gets DCGI gesture for world’s first medication to treat liver illness Kumar Jeetendra | March 6, 2020 Zydus Cadila has gotten endorsement from the Drug Controller General of India (DCGI) for its new medication application for Saroglitazar to treat a specific state of liver, regularly known as NASH in India, the medication major said on Thursday. The Ahmedabad-based organization said the affirmed item is the first since forever tranquilize anyplace on the …
Coronavirus medication: A joint inflammation medication could be the appropriate response everybody is searching for Kumar Jeetendra | March 5, 2020 10 years old medication used to treat irritation in joint inflammation patients could be the response to the world’s apprehensions of the coronavirus. Actemra, an enemy of irritation medicate made by Swiss drugmaker Roche, has been endorsed by the Chinese government to treat serious coronavirus manifestations. This comes when nations around the globe are urgently …
Dr. Reddy’s announces the launch of therapeutic equivalent generic version of Vimovo® Kumar Jeetendra | February 27, 2020 Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives today announced the first to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA). “This …
Cipla SA Signs Agreement For Anti-Psychotic Drug Kumar Jeetendra | February 10, 2020 Mumbai, India; February 10, 2020: As part of its quest to provide access to life-saving medication and making a difference in the lives of patients, Cipla Medpro South Africa (Pty) Limited (“Cipla Medpro”), wholly-owned subsidiary of Cipla Limited, India (“Cipla”) and South Africa’s third largest pharmaceutical company in the private sector, has recently concluded an …
Cipla Expands Women’s Health Portfolio through Acquisition of 4 Key Brands from Wanbury Kumar Jeetendra | February 8, 2020 Mumbai, India; February 08, 2020: Cipla Ltd. (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced the acquisition of nutrition products’ portfolio from Wanbury Ltd. Cipla has acquired 4 brands — CPink, CDense, Productiv and Folinine to further strengthen its presence in women’s health. The nutraceutical products, to be sold under …
Pharmaceutical quality control: the reference standards labyrinth Kumar Jeetendra | December 4, 2019 Dr. Martina Kotthaus, describing the different types of reference standards used by the pharmaceutical industry. Types of pharmaceutical reference standard (RS) In the pharmaceutical area, there are four major types of reference standards: Primary RS Pharmacopoeial RS (for monograph use) Secondary RS Impurity RS Apart from the pharmacopoeial standards, all of the above come with …
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carnas Kinase Inhibitor Kumar Jeetendra | November 1, 2019 SeraNovo B.V. announced that it has signed a License Agreement with Carna Biosciences, Inc., a company engaged in drug development specializing in the development of kinase inhibitors. Under the agreement, the companies will expand their existing collaboration and jointly continue to develop an oral formulation with increased bioavailability. Utilizing its proprietary Deep Eutectic Solvent (DES) …
New microdosing machine for sterile powders Kumar Jeetendra | October 22, 2019 Romaco will launch the new Macofar MicroMaxX 24 aseptic powder filling machine at the upcoming CIPM in Chongqing. The single-source supplier will also show selected tableting and processing technologies from Kilian and Innojet. Romaco Macofar MicroMaxX 24 microdosing machine Romaco’s new, intermittent motion Macofar MicroMaxX 24 microdosing machine will be launched in the market to …
